Prima Biomed (PBMD) PT Raised to $5 at Maxim Group Amid CVac Partnership
Tweet Send to a Friend
Maxim Group analyst Jason McCarthy reiterated a Buy rating and bumped his price target on Prima Biomed (NASDAQ: PBMD) to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE